Oncolytic Herpes Simplex Virus-Based Therapies for Cancer

With the increased worldwide burden of cancer, including aggressive and resistant cancers, oncolytic virotherapy has emerged as a viable therapeutic option. Oncolytic herpes simplex virus (oHSV) can be genetically engineered to target cancer cells while sparing normal cells. This leads to the direct...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cells
Hlavní autoři: Aldrak, Norah, Alsaab, Sarah, Algethami, Aliyah, Bhere, Deepak, Wakimoto, Hiroaki, Shah, Khalid, Alomary, Mohammad N., Zaidan, Nada
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2021
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8235327/
https://ncbi.nlm.nih.gov/pubmed/34207386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10061541
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky